Here’s one thing that will cost less next year—what it means for Medicare beneficiaries
admin This article is reprinted by permission from NerdWallet. While inflation is pushing up prices for…
Read Moredementia
Getting Medicare to cover Eisai and Biogen’s promising new Alzheimer’s therapy is ‘another bridge to cross’
An experimental Alzheimer’s disease treatment developed by Eisai and Biogen that appears to slow cognitive…
Read MoreRegulatory approval is next: Mizuho lifts Biogen to buy on news of Alzheimer’s drug success
Next stop regulatory approval. That was the view of analysts at Mizuho Securities, who late…
Read MoreEisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
Eisai Co. shares were indicated sharply higher Wednesday morning after the Japanese drug maker and…
Read MoreAlzheimer’s drug from Eisai, Biogen shows promise in large trial
Eisai Co. 4523, +0.89% and Biogen Inc. BIIB, +1.04% said their experimental Alzheimer’s disease drug…
Read MoreLarge-scale study finds COVID patients at higher risk of brain fog and psychosis after two years compared with other respiratory illnesses
People who have had COVID-19 are facing a higher risk of neurological and psychiatric conditions…
Read MoreA new type of service dog is helping people with dementia
An incident on his bike was the catalyst for John Wood getting a service dog.…
Read MoreOpinion: This is now the No. 1 preventable cause of Alzheimer’s in America
Here is yet more bleak news about the obesity epidemic: Obesity isn’t just killing millions…
Read More
Cold sores and shingles may be linked to Alzheimer’s, new research indicates
Could cold sores plus shingles lead to Alzheimer’s? New research from Tufts and Oxford universities…
Read More